|
Single Gene Disorders and Disability (SGDD) |
In 2005, CDC received money from Congress to start public health
activities for FXS. CDC is working with the National Fragile X
Foundation and other partners to find out more about FXS. Current
CDC priorities for FXS are to:
- Conduct epidemiologic research - collect information on topics such
as:
|
How common are the fragile X full mutation and premutation? |
|
Are the full mutation and premutation equally common among racial
and ethnic groups? |
|
How often do premutation
carriers have certain
health problems (FXTAS, POF, and cognitive and mood disorders)? |
|
What are the risk factors for premutation carriers to develop
health problems? |
- Improve screening and diagnosis
|
What are the early signs and symptoms of FXS? |
|
Are tests available for effective early screening? |
- Improve services to patients and families - outreach, education and
awareness
|
What medical and social services are patients and their families
receiving? |
|
Do different populations receive different care? |
|
What services do patients and their families need that are hard to
get? |
Currently, CDC and its partners are involved in the following
projects that are trying to answer some of the previous questions:
[Return to top of page]
Date: August 28, 2006
Content source: National Center on Birth Defects and Developmental
Disabilities
|
|
|